Fox Run Management L.L.C. Takes Position in Steris PLC (STE)
Fox Run Management L.L.C. bought a new position in Steris PLC (NYSE:STE) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 2,329 shares of the medical equipment provider’s stock, valued at approximately $266,000.
A number of other hedge funds have also modified their holdings of STE. Citigroup Inc. increased its holdings in Steris by 18.1% in the first quarter. Citigroup Inc. now owns 4,406 shares of the medical equipment provider’s stock worth $411,000 after purchasing an additional 674 shares in the last quarter. Allianz Asset Management GmbH increased its holdings in Steris by 47.3% in the first quarter. Allianz Asset Management GmbH now owns 138,158 shares of the medical equipment provider’s stock worth $12,898,000 after purchasing an additional 44,358 shares in the last quarter. A.R.T. Advisors LLC bought a new stake in Steris in the first quarter worth approximately $1,444,000. Barclays PLC increased its holdings in Steris by 374.8% in the first quarter. Barclays PLC now owns 47,317 shares of the medical equipment provider’s stock worth $4,418,000 after purchasing an additional 37,352 shares in the last quarter. Finally, Guggenheim Capital LLC increased its holdings in Steris by 41.3% in the first quarter. Guggenheim Capital LLC now owns 16,767 shares of the medical equipment provider’s stock worth $1,565,000 after purchasing an additional 4,897 shares in the last quarter. Institutional investors and hedge funds own 88.77% of the company’s stock.
A number of brokerages have weighed in on STE. Zacks Investment Research upgraded Steris from a “sell” rating to a “hold” rating in a report on Thursday, September 27th. KeyCorp lifted their target price on Steris from $115.00 to $120.00 and gave the stock an “overweight” rating in a report on Thursday, August 9th. Stephens reiterated a “buy” rating and issued a $125.00 target price on shares of Steris in a report on Thursday, August 9th. Finally, JMP Securities lifted their target price on Steris from $113.00 to $125.00 and gave the stock a “market outperform” rating in a report on Thursday, August 9th. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Steris has an average rating of “Buy” and an average price target of $100.86.
NYSE STE opened at $106.10 on Friday. The company has a market cap of $9.67 billion, a PE ratio of 25.24 and a beta of 1.06. Steris PLC has a 52 week low of $82.88 and a 52 week high of $117.48. The company has a quick ratio of 2.02, a current ratio of 2.65 and a debt-to-equity ratio of 0.43.
Steris (NYSE:STE) last released its quarterly earnings data on Wednesday, August 8th. The medical equipment provider reported $1.00 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.99 by $0.01. The firm had revenue of $638.76 million during the quarter, compared to the consensus estimate of $638.63 million. Steris had a return on equity of 11.80% and a net margin of 11.42%. The company’s quarterly revenue was up 5.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.85 earnings per share. On average, equities analysts anticipate that Steris PLC will post 4.71 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 27th. Stockholders of record on Wednesday, August 29th were issued a dividend of $0.34 per share. This is an increase from Steris’s previous quarterly dividend of $0.31. The ex-dividend date of this dividend was Tuesday, August 28th. This represents a $1.36 annualized dividend and a dividend yield of 1.28%. Steris’s payout ratio is currently 32.77%.
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Featured Article: Should you buy a closed-end mutual fund?
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.